ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

SAGE Sage Therapeutics Inc

14.18
0.00 (0.00%)
プレマーケット
最終更新日: 20:00:06
15分遅延
名称 銘柄コード 市場 種別
Sage Therapeutics Inc SAGE NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 14.18 20:00:06
始値 安値 高値 終値 前日終値
14.18
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2519:30BWSage Therapeutics Announces First Quarter 2024 Financial..
2024/4/1719:30BWSage Therapeutics Announces Topline Results from Phase 2..
2024/4/1119:30BWSage Therapeutics to Report First Quarter 2024 Financial..
2024/2/2820:30BWSage Therapeutics to Present at Upcoming March Investor..
2024/2/2206:35EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2024/2/1607:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1607:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:09EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2024/2/1421:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/1421:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1420:45EDGAR2Form 8-K - Current report
2024/2/1420:30BWSage Therapeutics Announces Fourth Quarter and Full Year..
2024/2/0107:25EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2024/2/0106:50EDGAR2Form 8-K - Current report
2024/1/3120:30BWSage Therapeutics to Report Fourth Quarter and Full Year..
2024/1/2506:10EDGAR2Form 8-K - Current report
2024/1/2322:13EDGAR2Form SC TO-I - Tender offer statement by Issuer
2024/1/0820:45EDGAR2Form 8-K - Current report
2024/1/0820:32BWSage Therapeutics to Provide Business Updates at 42nd Annual..
2024/1/0820:30BWSage Therapeutics Announces Changes to Board of Directors
2024/1/0506:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0220:30BWSage Therapeutics to Present at the 42nd Annual J.P. Morgan..
2023/12/1922:32EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2023/12/1922:30EDGAR2Form DEF 14A - Other definitive proxy statements
2023/12/1420:30BWZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
2023/12/0823:00EDGAR2Form SC TO-C - Written communication relating to an issuer..
2023/12/0822:30EDGAR2Form PRE 14A - Other preliminary proxy statements
2023/11/0820:30BWSage Therapeutics to Present at Upcoming November Investor..
2023/11/0721:39EDGAR2Form 8-K - Current report
2023/11/0721:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0721:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0720:46EDGAR2Form 8-K - Current report
2023/11/0720:30BWSage Therapeutics Announces Third Quarter 2023 Financial..
2023/10/2419:30BWSage Therapeutics to Report Third Quarter 2023 Financial..
2023/10/1820:10DJNSage Therapeutics Gets FDA Orphan Designation for SAGE-718..
2023/10/1819:30BWSage Therapeutics Announces U.S. Food and Drug..
2023/9/0619:30BWSage Therapeutics to Present at Upcoming September Investor..
2023/8/3119:45EDGAR2Form 8-K - Current report
2023/8/3119:30BWSage Therapeutics Implements Strategic Reorganization to..
2023/8/1121:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0820:51IHMARKETNEWSTuesday’s Wall Street Highlights: Novo Nordisk, RingCentral,..
2023/8/0721:18DJNSage Therapeutics Shares Slide Premarket After Zurzuvae MDD..
2023/8/0720:49EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0720:26IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
2023/8/0720:23DJNSage Therapeutics Mulls Job, Pipeline Cuts After FDA..
2023/8/0719:45EDGAR2Form 8-K - Current report
2023/8/0719:30BWSage Therapeutics Announces Second Quarter 2023 Financial..
2023/8/0511:45BWSage Therapeutics to Host Business Update Webcast and..
2023/8/0511:42BWFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
2023/6/0519:30BWSage Therapeutics to Present at the Goldman Sachs 44th..

最近閲覧した銘柄

Delayed Upgrade Clock